We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Trade like a pro: Leverage real-time discussions and market-moving ideas to outperform.
The current ARCT market cap is 1.11B. The company's latest EPS is USD -1.1044 and P/E is -36.84.
| Quarter End | Mar 2023 | Jun 2023 | Sep 2023 | Dec 2023 | Mar 2024 |
|---|---|---|---|---|---|
| USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
| Total Revenue | 80.29M | 10.52M | 45.14M | 33.99M | 38.01M |
| Operating Income | 14.76M | -73.25M | -18M | -15.14M | -30.41M |
| Net Income | 50.75M | -70.43M | 1.66M | -8.57M | -26.82M |
| Year End December 30 2023 | 2019 | 2020 | 2021 | 2022 | 2023 |
|---|---|---|---|---|---|
| USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
| Total Revenue | 20.79M | 9.54M | 12.36M | 206M | 166.8M |
| Operating Income | -25.55M | -71.79M | -202.34M | 11.66M | -78.21M |
| Net Income | -25.99M | -72.15M | -203.67M | 9.35M | -29.73M |
| Quarter End | Mar 2023 | Jun 2023 | Sep 2023 | Dec 2023 | Mar 2024 |
|---|---|---|---|---|---|
| USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
| Total Assets | 470.86M | 430.65M | 457.65M | 429.4M | 418.85M |
| Total Liabilities | 141.62M | 145.47M | 177.59M | 147.76M | 154.88M |
| Total Equity | 329.25M | 285.18M | 280.06M | 281.65M | 263.97M |
| Year End December 30 2023 | 2019 | 2020 | 2021 | 2022 | 2023 |
|---|---|---|---|---|---|
| USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
| Total Assets | 82.14M | 476.46M | 392.81M | 450.39M | 429.4M |
| Total Liabilities | 56.35M | 79.9M | 164.6M | 180.08M | 150.89M |
| Total Equity | 25.79M | 396.55M | 228.21M | 270.31M | 278.51M |
| Quarter End | Mar 2023 | Jun 2023 | Sep 2023 | Dec 2023 | Mar 2024 |
|---|---|---|---|---|---|
| USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
| Operating | -35.87M | 14.94M | -17.47M | N/A | -5.56M |
| Investing | -691k | -1.05M | -2.03M | N/A | -240k |
| Financing | -27.36M | -27.27M | -5.43M | N/A | 2.19M |
| Year End December 30 2023 | 2019 | 2020 | 2021 | 2022 | 2023 |
|---|---|---|---|---|---|
| USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
| Operating | -6.45M | -42.86M | -135.04M | 31.99M | -18.1M |
| Investing | -818k | -1.74M | -3.41M | -7.73M | -2.9M |
| Financing | 41.91M | 436.15M | 48.02M | -2.86M | -24.09M |
| Market Cap | 1.11B |
| Price to Earnings Ratio | -36.84 |
| Price to Sales Ratio | 6.57 |
| Price to Cash Ratio | 3.75 |
| Price to Book Ratio | 3.93 |
| Dividend Yield | - |
| Shares Outstanding | 26.92M |
| Average Volume (1 week) | 572.55k |
| Average Volume (1 Month) | 493.81k |
| 52 Week Change | 55.36% |
| 52 Week High | 43.81 |
| 52 Week Low | 17.52 |
| Spread (Intraday) | 2.5 (5.88%) |
| Company Name | Arcturus Therapeutics Holdings Inc |
| Address |
10628 science center drive, suite 250 san diego, california 92121 |
| Website | https://arcturusrx.com |
| Industry | pharmaceutical preparations (2834) |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions
Hot Features
Premium
